TWST

Twist Bioscience Corporation manufactures and sells synthetic DNA-based products. It offers synthetic genes and gene fragments used in product development for therapeutics, diagnostics, chemicals/materials, food/agriculture, data storage, and various applications within academic research by biotech, pharma, industrial chemical, and agricultural companies, as well as academic labs; Oligo pools used in targeted NGS, CRISPR gene editing, mutagenesis experiments, DNA origami, DNA computing, data storage in DNA, and other applications; and immunoglobulin G proteins for customers focused on the pursuit of drug discovery and development.

Twist Bioscience Corporation (TWST) is a healthcare company listed on Nasdaq, traded in USD. Over the past year it moved between $23.30 and $219.71. The 12 analysts covering it say Buy, with an average price target of $168.25. Its next earnings report is on November 12, 2026.

• Healthcare
• Biotechnology
• South San Francisco, United States
• 979 employees
• Led by Emily Marine Leproust Ph.D.